Learning Objective: Upon completion of this activity, participants will be able to:
Review current evidence about how to prevent the rare but potentially fatal complication of administering metformin to diabetic patients.
Faculty: Serena Cardillo, MD, CCMEP
Assistant Professor of Medicine
Clinician, Penn Rodebaugh Diabetes Center
Division of Endocrinology, Diabetes & Metabolism
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
and Mark H. Schutta, MD
Clinical Assistant Professor of Medicine
Division of Endocrinology, Diabetes & Metabolism
University of Pennsylvania
Director, Penn Rodebaugh Diabetes Center
Philadelphia, Pennsylvania
Last Review Date: June 15, 2010 Expiration Date: June 14, 2012
Amount of CME Credit: Maximum of 0.25 AMA PRA Category 1 Credit(s)™
Estimated Time to Complete: 10 to15 minutes
Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Pennsylvania School of Medicine and BestPractice CPD. The University of Pennsylvania School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit: The University of Pennsylvania School of Medicine designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Supported, in part, by educational grants from Genentech, GlaxoSmithKline, Lilly USA, LLC, Takeda Pharmaceuticals North America, Inc.
Login/Register to begin
